Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

BNT162b2 mRNA COVID-19 vaccine three-dose safety and risk of COVID-19 in patients with myasthenia gravis during the alpha, delta, and omicron waves
A. Doron, Yoav Piura, Ifat Vigiser, et al.
Journal of Neurology (2022) Vol. 269, Iss. 12, pp. 6193-6201
Open Access | Times Cited: 18

Showing 18 citing articles:

Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations
Koos P J van Dam, Luuk Wieske, Eileen W Stalman, et al.
Journal of Autoimmunity (2023) Vol. 135, pp. 102984-102984
Open Access | Times Cited: 18
Risk of flare or relapse in patients with immune-mediated diseases following SARS-CoV-2 vaccination: a systematic review and meta-analysis
Mahya Shabani, Parnian Shobeiri, Shadi Nouri, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 5
Neurological Disorders following COVID-19 Vaccination
Ying Yang, Lisu Huang
Vaccines (2023) Vol. 11, Iss. 6, pp. 1114-1114
Open Access | Times Cited: 8
COVID-19 in patients with myasthenia gravis: a single-center retrospective study in China
Jiayi Li, Yiming Zheng, Yawen Zhao, et al.
Neurological Sciences (2024) Vol. 45, Iss. 7, pp. 2969-2976
Closed Access | Times Cited: 3
COVID-19 Vaccination and Late-Onset Myasthenia Gravis: A New Case Report and Review of the Literature
Eleonora Virgilio, Giacomo Tondo, Claudia Montabone, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 20, Iss. 1, pp. 467-467
Open Access | Times Cited: 12
Effectiveness of Booster Doses of the SARS-CoV-2 Inactivated Vaccine KCONVAC against the Mutant Strains
Chanchan Xiao, Jun Su, Chanjuan Zhang, et al.
Viruses (2022) Vol. 14, Iss. 9, pp. 2016-2016
Open Access | Times Cited: 10
Safety of COVID-19 vaccine in patients with myasthenia gravis: a self-controlled case series study
Zhe Ruan, Xiao Huan, Yue Su, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Association between COVID‐19 and myasthenia gravis (MG): A genetic correlation and Mendelian randomization study
Dongren Sun, Liangdan Tu, Xiaofei Wang, et al.
Brain and Behavior (2023) Vol. 13, Iss. 11
Open Access | Times Cited: 5
Safety of SARS-CoV-2 vaccine in patients with autoimmune neurological conditions: A systematic review and meta-analysis
Fan Ning, Xiang-qi Cao, Qingqing Wang, et al.
Heliyon (2023) Vol. 10, Iss. 1, pp. e23944-e23944
Open Access | Times Cited: 4
Comparing the Impact of COVID-19 on Vaccinated and Unvaccinated Patients Affected by Myasthenia Gravis
Elena Scarsi, Sara Massucco, Pilar M. Ferraro, et al.
Life (2023) Vol. 13, Iss. 4, pp. 1064-1064
Open Access | Times Cited: 3
The safety of COVID-19 vaccines in patients with myasthenia gravis: A scoping review
Siyang Peng, Yukun Tian, Linghao Meng, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 4
Safety of SARS-CoV-2 vaccines in patients with myasthenia gravis: a meta-analysis
Qian Zheng, Yongran Cheng, Chengxin Song, et al.
Neurological Sciences (2023) Vol. 44, Iss. 9, pp. 2999-3003
Open Access | Times Cited: 1
The COVID-19 pfizer BioNTech mRNA vaccine and the frequency of seizures
A. Doron, Tamar Eviatar‐Ribak, Aya Vituri, et al.
Clinical Neurology and Neurosurgery (2023) Vol. 233, pp. 107952-107952
Closed Access | Times Cited: 1
Patient‐reported daily functioning after SARS‐CoV‐2 vaccinations in autoimmune neuromuscular diseases
Koos P J van Dam, Luuk Wieske, Eileen W Stalman, et al.
European Journal of Neurology (2024)
Open Access
The Impact of COVID-19 Vaccination and Infection on the Exacerbation of Myasthenia Gravis
Yuting Jiang, Jingsi Wang, Shengyao Su, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1221-1221
Open Access
COVID-19 vaccination in myasthenia gravis: safe, but predictors of disease exacerbation yet to be determined
Sohyeon Kim, Mi‐Yeon Eun, Hung Youl Seok
Neurological Sciences (2023) Vol. 44, Iss. 5, pp. 1503-1504
Open Access
Safety of SARS-CoV-2 vaccine in patients with autoimmune neurological conditions: a systematic review and meta-analysis
Fan Ning, Xiang-qi Cao, Qingqing Wang, et al.
Authorea (Authorea) (2023)
Open Access
Safety and neutralization antibody levels of inactivated SARS-CoV-2 vaccine in adult patients with Myasthenia Gravis: a prospective observational cohort study
Wei Zheng, Xiaoxia Cao, Jing Luo, et al.
Neurological Sciences (2023) Vol. 45, Iss. 4, pp. 1707-1717
Closed Access
Page 1

Scroll to top